Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
For consumers, blockchain offers greater control over data and transactions. This intro explains benefits with relatable scenarios.
21,901 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
SDNY prosecutors seek a new trial for Tornado Cash co-founder Roman Storm in October 2026, even as U.S. agencies ackn...
Markets tilt away from AI hype toward real-world assets as the Great Rotation accelerates. TerraTread debuts a durabl...
Adobe is navigating a fast-changing software landscape in 2026. This guide breaks down the 2026 earnings outlook, key...
Two popular tech ETFs sit on opposite ends of the spectrum: a broad technology exposure semiconductor approach with V...
This year’s best picture oscar nominee lineup reveals a dramatic shift in where movies are made, with major economic ...
A week of trouble tested Amazon's operations and investor nerves. This article breaks down two essential takeaways an...
A high-profile moment in a living room reveals a bigger truth: politics at home can ripple into your wallet. This art...
What if you could turn rental properties into a reliable income stream in just a few years? This guide shares five pr...
A new deduction for interest on auto loans for 2025 buyers could cut tax bills even for standard-deduction filers. Bu...
Choosing the right global real estate ETF can boost income and diversification. This guide compares VNQI and REET, hi...
A major Bitcoin whale flipped from long to short, taking a 2,281 BTC position on Binance with a $169 million nominal ...